Stockreport

Pacira BioSciences: Mispriced On Generic Risks That Are Years Away [Seeking Alpha]

Pacira BioSciences, Inc.  (PCRX) 
Last pacira biosciences, inc. earnings: 2/20 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.pacira.com
PDF EXPAREL's manufacturing complexity and hospital adoption create a significant moat, making immediate generic substitution unlikely even after patent setbacks. The NOP [Read more]